Any of the adverse reactions listed as follows may occur. Therefore, patients receiving Elobixibat (GOOFICE) treatment should be carefully monitored, and if any abnormalities are noted, appropriate measures should be taken including discontinuation of Elobixibat (GOOFICE) treatment. (See Table 3.)
Click on icon to see table/diagram/image